Back to drug safety directory
Dopamine D2/D3 agonist (Parkinson's disease, restless legs syndrome)Reviewed May 23, 2026

Ropinirole (Requip) and Ketamine Therapy | Tovani Health

Requip (Ropinirole) (also: Requip XL)Dopamine D2/D3 agonist (Parkinson's disease, restless legs syndrome)

Verdict at Tovani Health

Fully compatible with KAP; impulse-control side effects are intrinsic to dopamine agonists.

Ropinirole and ketamine have no clinically significant interaction. Common dopamine agonist for early Parkinson's disease and restless legs syndrome. The famous safety consideration — impulse-control disorders (compulsive gambling, hypersexuality, binge eating, shopping) that develop in a subset of patients on dopamine agonists — is intrinsic and important to screen for. Doesn't change with KAP. Sudden-onset sleep attacks are a less-common but real intrinsic risk.

If you take Requip regularly and are considering at-home ketamine therapy, the combination is generally safe at therapeutic doses. This page covers the brief pharmacologic context and what we do at intake.

How Requip interacts with ketamine

Selective D2/D3 receptor agonist. CYP1A2 substrate (smoking and ciprofloxacin matter for ropinirole levels independent of KAP). No clinically significant CYP interaction with ketamine.

What we do at intake

Continue as prescribed. Tell us about any impulse-control side effects (we ask, even if uncomfortable).

Bottom line

Ropinirole and ketamine have no clinically significant interaction. Common dopamine agonist for early Parkinson's disease and restless legs syndrome. The famous safety consideration — impulse-control disorders (compulsive gambling, hypersexuality, binge eating, shopping) that develop in a subset of patients on dopamine agonists — is intrinsic and important to screen for. Doesn't change with KAP. Sudden-onset sleep attacks are a less-common but real intrinsic risk.

Ready to find out if at-home ketamine fits your situation?

We’ll note that you’re on Requip (Ropinirole) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.

FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.

Clinically reviewed

Reviewed by Benjamin Soffer, DO on May 23, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.

This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.